✦ LIBER ✦

956 Transarterial Chemoembolization Combined With Celecoxib and Lanreotide in the Treatment of Unresectable Hepatocellular Carcinoma: A Prospective Randomized Controlled Trial

✍ Scribed by Li, Xiao; Tong, Huan; Wei, Bo; Zhang, Mingguang; Huang, Zhiyin; Tang, Chengwei

Book ID: 122249192
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 205 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63592-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transarterial chemoembolization in patie

Transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: A meta-analysis of randomized controlled trials

✍ Filippo Schepis; Ambmgio Orlando; Maddalena Albanese; Franco Trevisani; Pietro A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Transarterial embolization versus sympto

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution

✍ Jordi Bruix; Josep M. Llovet; Antoni Castells; Xavier Montañá; Concepció Brú; Ma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Midterm outcomes in patients with interm

Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma : A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization

✍ Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

The safety and efficacy of transcatheter

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction : A prospective controlled study

✍ Hyo-Suk Lee; Joo Sung Kim; Il Ju Choi; Jin Wook Chung; Jae Hyung Park; Chung Yon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 3 views

## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co

1243 Octreotide treatment in patients wi

1243 Octreotide treatment in patients with advanced hepatocellular carcinoma: first results of the randomized placebo-controlled double-blind Hector trial

✍ ALLGAIER, H; BECKER, G; OLSCHEWSKI, M; ZAHRINGER, A; BLUM, H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w